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Colony stimulating factor-1 (Csf-1) receptor and its
ligandCsf-1controlmacrophagedevelopment,main-
tenance, and function. The development of both
Langerhans cells (LCs) andmicroglia is highly depen-
dent on Csf-1 receptor signaling but independent
of Csf-1. Here we show that in both mice and
humans, interleukin-34 (IL-34), an alternative ligand
for Csf-1 receptor, is produced by keratinocytes in
the epidermis and by neurons in the brain. Mice lack-
ing IL-34 displayed a marked reduction of LCs and
adecrease ofmicroglia, whereasmonocytes, dermal,
and lymphoid tissue macrophages and DCs were
unaffected. We identified IL-34 as a nonredundant
cytokine for the development of LCs during embryo-
genesis as well as for their homeostasis in the adult
skin. Whereas inflammation-induced repopulation
of LCs appears to be dependent on Csf-1, once
inflammation is resolved, LC survival is again IL-34-
dependent. In contrast, microglia and their yolk sac
precursors develop independently of IL-34 but rely
on it for their maintenance in the adult brain.
INTRODUCTION
In both mice and humans, the epidermis and the central
nervous system (CNS) are colonized by homogenous and onto-
genically unique populations of the mononuclear phagocyte
system (MPS), namely Langerhans cells (LCs) and microglia.
LCs are the dendritic cells (DCs) of the epidermis and form1050 Immunity 37, 1050–1060, December 14, 2012 ª2012 Elsevier Inthe first immune barrier to foreign antigens that breach the
skin. Microglia represent the resident macrophages of the
CNS and are considered the first line of defense in many CNS
pathologies. Most lymphoid and nonlymphoid tissue DCs and
macrophages are constantly repopulated by blood-derived
circulating myeloid precursors. In contrast, epidermal LCs and
microglia derive from embryonic precursors that take residence
in the skin and brain prior to birth and are maintained locally
throughout adult life in the steady state (Ginhoux et al., 2010;
Hoeffel et al., 2012; Merad et al., 2002). Apart from the cytokine
transforming growth factor b (TGF-b), which is essential for the
maintenance of LCs (Kaplan et al., 2007), the local cutaneous
growth factors that control LC homeostasis are only now being
discovered (Wang et al., 2012). As for microglia, the factors that
govern their development and maintenance remain largely
unclear.
Csf-1 is a critical growth factor for the generation, differentia-
tion, and survival of macrophages and monocytes (Dai et al.,
2002; Wiktor-Jedrzejczak et al., 1990). Mice lacking Csf-1
receptor (Csf-1r) or bearing a spontaneous null mutation in
Csf-1 (Csf1op/op) display greatly reduced macrophage popula-
tions in various tissues including osteoclasts, leading to multiple
developmental defects such as impaired bone remodeling,
osteopetrosis, and tooth eruption (Dai et al., 2002). In particular,
mice deficient in Csf-1r also lack epidermal LCs and microglia
(Ginhoux et al., 2006, 2010). Interestingly however, in contrast
to Csf1r/ mice, Csf1op/op mice display relatively normal LC
and microglia development (Ginhoux et al., 2006), suggesting
that an alternative ligand for Csf-1r controls the maintenance
of these two cell populations in vivo. Interleukin-34 (IL-34)
has been identified as an additional ligand for Csf-1r and was
shown to bind Csf-1r with high affinity in vitro (Garceau et al.,
2010; Lin et al., 2008). IL-34 is more conserved in mammalian
and avian species than Csf-1 (Garceau et al., 2010). IL-34 andc.
CD
11
b
MHCII
LangCre+ x Csf1r
A
Control
0
20
40
60 ***
0 102 103 104 105
0
102
103
104
105 30.8
0 102 103 104 105
0
102
103
104
105 0.91
CD
11
b
MHCII
Control Csf1r-/-
Csf1op/op
0
20
40
60 Csf1op/op
Control
53.7
0 102 103 104 105
0
102
103
104
105
55.8
0 102 103 104 105
0
102
103
104
105
2.36
0 102 103 104 105
0
102
103
104
10547.5
0 102 103 104 105
0
102
103
104
105
CD
11
b
MHCII
Csf1r-/-
Control
0
50
100
150
200
250 ***
B
C
CD
11
b
Langerin
0 102 103 104 105
0
102
103
104
105 8.25
P1
P5
P10
Ce
ll 
nu
m
be
r (
x1
02
)
Ce
ll 
nu
m
be
r (
x1
02
)
0
50
100
150
200
Ce
ll 
nu
m
be
r (
x1
02
)
LangCre-x Csf1r
LangCre+x Csf1r
66.8
0 102 103 104 105
0
102
103
104
105
38.3
0 102 103 104 105
0
102
103
104
105
40.4
0 102 103 104 105
0
102
103
104
105
CD
11
b
Langerin
CD
11
b
Langerin
LangCre-x Csf1r
LangCre+x Csf1r
0
20
40
60
**LangCre+ x Csf1rLangCre- x Csf1r
LangCre+ x Csf1rLangCre- x Csf1r
LangCre+ x Csf1rLangCre- x Csf1rD
9.1
0 102 103 104 105
0
102
103
104
105
54.8
0 102 103 104 105
0
102
103
104
105
10.458.1
Ce
ll 
nu
m
be
r (
x 
10
2 )
Ce
ll 
nu
m
be
r (
x 
10
2 )
Ce
ll 
nu
m
be
r (
x 
10
2 )
R2R1
Control
Control
E
CD
11
b
MHCII
αCsf-1r 
Isotype
αCsf-1r
***Isotype CreER
T2+ x Csf1rCreERT2- x Csf1r
30.5
0 102 103 104 105
0
102
103
104
105 1.01
0 102 103 104 105
0
102
103
104
105
CD
11
b
MHCII
0
5
10
15
CreERT2- x Csf1r
CreERT2+ x Csf1r
F
R1 R2
0
20
40
60
80
100
120
Ce
ll 
nu
m
be
r (
x1
02
)
LangCre+x Csf1r
LangCre-x Csf1r
LangCre+x Csf1r
Ce
ll 
nu
m
be
r (
x1
02
)
0 102 103 104 105
0
102
103
104
105
14
0 102 103 104 105
0
102
103
104
105
2.84
0
20
40
60
Figure 1. Csf-1r Signaling Is Critical for LC Homeostasis in Adult Skin
(A–F) Plots show the percentage and total cell number (±SEM) of LCs among CD45+ epidermal cells in adult mice (A–C, E and F) or neonates on postnatal day (p)1,
p5, and p10 (D). Graphs represent data of pooled experiments. *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test, unpaired). (A) Csf1r/ and control mice
(Csf1r+/ orCsf1r+/+) (nR 3). (B)Csf1op/op and control mice (Csf1op/+ orCsf1+/+) (n = 5). (C) Langerin (Lang) Cre+3Csf1rfl/fl or control mice (LangCre+3Csf1rfl/+ or
LangCre3 Csf1rfl/fl) (n = 4). (D) LangCre+3 Csf1rfl/fl or LangCre3 Csf1rfl/fl neonates. On p1, R1 represents LC precursors (Langerin) and R2 represents LCs
(Langerin+). p2: n = 6, p5: n R 3, p10: n R 6. (E) Anti-(a)Csf-1r treated or isotype treated WT mice (n = 6). One representative of at least three individual
experiments is shown.
(F) Rosa26-CreERT2+ (CreERT2+)3 Csf1rfl/fl and CreERT23 Csf1rfl/fl mice were treated with tamoxifen and the skin was analyzed 7 days post treatment (n = 2).
One representative of two individual experiments is shown.
Immunity
IL-34 Controls Langerhans Cells and MicrogliaCsf-1 were shown to bind on different regions of the Csf-1r
and share no overt sequence homology (Chihara et al., 2010).
IL-34 can promote the survival and proliferation of human
monocytes and stimulate macrophage colony formation of
human bone marrow (BM) cells (Lin et al., 2008). However, the
role of IL-34 in the development and maintenance of LCs and
microglia in vivo is only now becoming clearer (Wang et al.,
2012). Here, by generating IL-34 deficient reporter mice, we
demonstrated that IL-34 is crucial for the embryonic develop-
ment of LCs and their homeostasis in the adult in the steady
state. During skin inflammation, IL-34 is not required for the
recruitment of monocytes and their subsequent differentiation
into LCs as was observed by Wang et al. (2012). However,
here we found it to be critical for their maintenance after inflam-
mation was resolved. In addition, IL-34 did not control the
embryonic development of microglia but contributed to micro-
glia homeostasis in the adult. Taken together, IL-34 is a
stroma-derived homeostatic cytokine and growth factor specif-
ically targeting two unique populations of the MPS, namely LCs
and microglia.ImmRESULTS
Csf-1r Signaling Is Critical for LC Homeostasis
As previously shown, Csf1op/op mice display only slightly
reduced numbers of LCs whereas Csf1r/mice are completely
devoid of LCs (Figures 1A and 1B) (Ginhoux et al., 2006).
However, in Csf1r/ embryos, LC precursors are lacking
already in the embryonic skin (Hoeffel et al., 2012). Thus, in order
to circumvent such developmental defect and to determine
whether Csf-1r signaling also controls LC homeostasis in the
adult skin, we generated mice in which Csf-1r was specifically
deleted in Langerin+ cells. Within the epidermis, Langerin
expression is only acquired after birth and restricted to LCs
(Merad et al., 2002; Tripp et al., 2004). We observed an almost
complete loss of LCs in adult Langerin-Cre+3Csf1rfl/fl mice (Fig-
ure 1C) demonstrating that Csf-1r not only controls LC embry-
onic development, but is also required for their maintenance
throughout adult life. Neonatal LC precursors, which are
Langerin, were present at normal numbers on postnatal day 1
in Langerin-Cre+ 3 Csfr1fl/fl neonates (Figure 1D). Only whenunity 37, 1050–1060, December 14, 2012 ª2012 Elsevier Inc. 1051
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Figure 2. IL-34 Is Expressed by Keratinocytes in the Epidermis and Controls the Development of LCs
(A) Quantitative RT-PCR analysis of Il34 mRNA expression of liver, brain, lung, spleen, and skin in WT mice. Data were normalized to the expression of RNA
polymerase 2 (n = 2). Shown is one representative of three individual experiments.
(B) Quantitative RT-PCR analysis of Il34 and Csf1mRNA expression of WT epidermis and dermis. Data were normalized to the expression of RNA polymerase 2
(n = 2). One representative of two individual experiments is shown.
(C) X-gal staining (blue) of skin sections from Il34LacZ/+ and Il34+/+ mice (scale bar represents 40 mm). HF, Hair follicle.
(D) Skin sections of Il34+/+ mice and Il34LacZ/+ mice were stained with X-gal (blue) and mAb against K14 (red) (scale bar represents 20 mm).
(E) Plots show the percentage and total cell number (±SEM) of LCs (CD11b+MHCII+) among CD45+ epidermal cells in adult Il34LacZ/LacZ and Il34LacZ/+mice (n = 5).
Pooled data of several individual experiments. *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test, unpaired).
(F) Images display anti-MHCII (LCs) and anti-CD3 (DETCs) staining on ear-derived epidermal sheets from adult Il34LacZ/LacZ and Il34LacZ/+ mice (scale bar
represents 50 mm).
Immunity
IL-34 Controls Langerhans Cells and MicrogliaLC precursors had differentiated into LCs (Langerin+) was the
Csf1r gene deleted, which led to the decrease in LC numbers
(Figure 1D). To confirm that Csf-1r controls LC homeostasis in
adult mice, we also treated wild-type (WT) mice with a neutral-
izing monoclonal antibody (mAb) to Csf-1r (AFS98) (Hashimoto
et al., 2011; Sudo et al., 1995). Extending previous results (Mac-
Donald et al., 2010), administration of anti-Csf-1r mAb in adult
animals resulted in depletion of LCs, again demonstrating that
Csf-1r signaling is critical for LC homeostasis in adult mice (Fig-
ure 1E). In addition, we used Rosa26-CreERT2+ 3 Csf1rfl/fl mice
to inducibly delete the Csf1r gene in adult mice upon tamoxifen
administration (Figure 1F). Also in this model, we found that
conditional deletion of Csf-1r in the adult led to depletion of
LCs indicating that Csf-1r signaling is required for the mainte-
nance of fully differentiated LCs in healthy adult skin.
IL-34 Is Expressed by Keratinocytes in the Epidermis
and Is Critical for the Development of LCs
IL-34 is an alternative ligand for Csf-1r (Lin et al., 2008) and its
activity could explain the phenotypic discrepancy between
Csf1op/op and Csf1r/mice. We found that IL-34 was highly ex-
pressed in the skin and in the brain compared to other nonlym-
phoid and lymphoid tissues e.g., liver, lung, and spleen (Fig-
ure 2A), as previously described (Wei et al., 2010). Within the
skin, Il34 was the only Csf-1r ligand expressed in the epidermis,
whereas both Il34 and Csf1 were expressed in the dermis (Fig-
ure 2B). In order to specifically trace IL-34 expression in vivo,1052 Immunity 37, 1050–1060, December 14, 2012 ª2012 Elsevier Inwe generated an IL-34 reporter mouse strain by targeting
a LacZ cassette into the endogenous IL-34 locus (Il34LacZ/+).
Within the skin, IL-34 was highly expressed by keratinocytes in
the epidermis (Figures 2C and 2D). We also detected weak
IL-34 reporter expression in the dermis localized to hair follicles
(Figure 2C). The high expression of IL-34 within the epidermis
suggests that IL-34 plays a role for the development or mainte-
nance of LCs.
In order to determine whether IL-34 controls LC homeostasis
in vivo, we generated mice deficient in IL-34 by crossing the
knockin reporter allele to homozygosity (Il34LacZ/LacZ). In contrast
to Csf1op/op mice (Dai et al., 2002), we did not detect overt
growth abnormalities or bone malformations in Il34LacZ/LacZ
mice. Also, the mice were born at normal Mendelian distribution.
In contrast, adult mice lacking IL-34 displayed a drastic reduc-
tion of LCs (Figures 2E and 2F). This, however, did not lead to
any overt macroscopic changes in the skin or fur, nor did we
observe signs of skin inflammation. Also, as previously reported
(Taveirne et al., 2011), the lack of LCs did not affect the numbers
or morphology of the epidermal resident population of gd T cells
(dendritic epidermal gd T cells, DETCs) (Figure 2F).
With the exception of migratory LCs, which were missing from
the skin draining lymph nodes in Il34LacZ/LacZmice (see Figure S1
available online), DCs in spleen, liver, and dermis as well as
DCs in skin draining lymph nodes were largely unaffected.
Circulating Ly6Chi and Ly6Clo monocytes, spleen macrophages,
lung alveolar macrophages, and macrophages in the liver andc.
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Figure 3. IL-34 Contributes to the Homeostasis of Adult Microglia
(A) X-gal staining (blue) of brain sections from Il34LacZ/+ and Il34+/+ mice (scale bar represents 200 mm).
(B) Brain sections of Il34LacZ/+ mice were stained with X-gal (blue) and NeuN (brown) (scale bar represents 50 mm).
(C) Plots show the percentage and total cell number (±SEM) of microglia (CD45+CD11b+F4/80+) in adult Il34LacZ/LacZ and Il34LacZ/+mice (n = 12). Pooled data of at
least four different experiments are shown. *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test, unpaired).
(D and E) Brain sections of Il34LacZ/LacZ and Il34LacZ/+ adult mice were stained with anti-Iba-1 (scale bar represents 200 mm).
(E) Mean number of microglia (Iba-1+ cells) per mm2 (n = 2).
Immunity
IL-34 Controls Langerhans Cells and Microgliadermis were also not affected in the absence of IL-34. Thus,
stroma-derived IL-34 within the skin is required for the develop-
ment of LCs.
IL-34 Contributes to the Maintenance of Microglia
in the Adult
Similar to the LC population, Csf1r/ mice lack microglia but
mice lacking Csf-1 display normal numbers of microglia (Gin-
houx et al., 2010). Given that IL-34 is highly expressed in the
brain (Figure 2A), we hypothesized that IL-34-mediated Csf-1r
signaling may be involved in the development and/or mainte-
nance of microglia. IL-34 reporter expression revealed that
within the brain, IL-34 is highly expressed predominantly in the
cortex, the anterior olfactory nucleus, and the hippocampus
(Figure 3A), whereas no or very low expression could be
detected in the brain stem and cerebellum (data not shown).
IL-34 was specifically expressed by neurons (Figure 3B) as pre-
viously suggested (Mizuno et al., 2011). In adult Il34LacZ/LacZ
mice, microglia were partially reduced, most pronounced inImmareas correlating with high IL-34 expression (Figures 3C–3E).
Thus, IL-34 contributes to microglia homeostasis in specific
areas of the brain.
IL-34 Controls the Embryonic Development of LCs
but Not Microglia
LCs arise from a pool of circulating precursors that take resi-
dence in the skin prior to birth.We have recently shown that adult
LCs derive predominantly from fetal liver monocytes, which seed
the skin around E14.5, but a fraction of LCs also derives from
yolk sac macrophages that are recruited to the skin at around
E10.5 (Hoeffel et al., 2012). To assess whether IL-34 also
controls the differentiation of LC precursors in the embryo and
their recruitment to the skin rudiment, we first examined the
expression profiles of Il34 and Csf1 during embryogenesis in
the developing skin and brain rudiment (Figures 4A and 4B).
E17.5 represents the earliest time point at which the epidermis
can be physically separated from the dermis (Hoeffel et al.,
2012). For time points before E17.5, we analyzed limb buds,unity 37, 1050–1060, December 14, 2012 ª2012 Elsevier Inc. 1053
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Figure 4. IL-34 Controls the Development of LCs during Embryogenesis
(A and B) Quantitative RT-PCR analysis of Il34 and Csf1mRNA expression in the developing skin (A) and the developing brain (B) at different time points during
embryogenesis and in newborn (NB) and adult WT mice. Total skin is shown from E12.5–E16.5, and epidermis and dermis are shown after E17.5. Data were
normalized to the expression of HPRT1 (n = 3). Shown are pooled data of two individual experiments.
(C) Plots show the percentage (among CD45+ cells) and total cell number (±SEM) of primitive macrophages (CD11b+F4/80+) in the yolk sac at E10.5 (nR 3).
(D) Plots show the percentage and total cell number (±SEM) (among CD45+ cells) of microglia precursors (CD11b+F4/80+) in the brain at E10.5, E14.5, and E17.5
and of LC precursors (CD11b+F4/80+) in the skin (limb buds) at E10.5 and E14.5 and in the epidermis at E17.5 in Il34LacZ/LacZ and Il34LacZ/+ embryos (for E10.5:
nR 3, for E14.5: nR 4 and for E17.5: n = 5). Data are pooled of 1–2 different experiments.
(E) Plots show the percentage and total cell number (±SEM) of epidermal LC precursors and microglia (both CD11b+F4/80+) among CD45+ cells in newborn
Il34LacZ/LacZ and Il34LacZ/+ mice (LC precursors: n = 2, microglia: n = 6). One representative of three individual experiments is shown. (C–E) *p < 0.05, **p < 0.01,
***p < 0.001 (Student’s t test, unpaired).
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Immunity
IL-34 Controls Langerhans Cells and Microgliawhich represent embryonic skin as previously described (Hoeffel
et al., 2012). We found that Csf1 and Il34were both expressed in
the CNS throughout embryogenesis as well as in newborns and
adult mice while Il34 was expressed at higher levels (Figure 4B).
In the developing skin, Csf1 was upregulated in the dermis at
E17.5 but not detectable in the epidermis. Conversely, Il34 tran-
scripts increased specifically in the epidermis at E17.5 and re-
mained at high levels after E17.5 at all later time points (Figures
2B and 4A). Before E17.5, both cytokines were expressed at low
levels in the skin. These data demonstrated that IL-34 is not only
the only Csf-1r ligand present in the adult epidermis but also in
the embryonic epidermis, suggesting a critical role for IL-34 in
LC development.
To verify whether IL-34 is required for the development of LCs,
we analyzed whether absence of IL-34 affected the differentia-
tion of LC precursors (F4/80+CD11b+) at E10.5, E14.5, and
E17.5. We found no difference in primitive macrophages and
LC precursors between Il34lacZ/lacZ and Il34LacZ/+ embryos in
the yolk sac at E10.5 or in the limb buds at E10.5 or E14.5,
respectively (Figures 4C and 4D). However the absence of IL-
34 strongly reduced the number of LC precursors within the
skin rudiment at E17.5 (Figure 4D) and the number of epidermal
LCs in newborns (Figure 4E). The disappearance of LCs in the
absence of IL-34 coincided with the increased Il34 expression
observed in the epidermis of WT embryos at this time point
(Figure 4A). Circulating monocytes, fetal liver, splenic, and
dermal monocytes, as well as macrophages in the spleen,
lung, dermis, and liver, were unaffected in embryos deficient in
IL-34 at E17.5 (Figure S2). This finding demonstrated that IL-34
specifically controls LC differentiation locally in the skin during
embryonic development.
In contrast to LCs, which predominantly arise from fetal liver
precursors (Hoeffel et al., 2012), microglia are exclusively
derived from primitive yolk sac macrophages that arise before
embryonic age E8 (Ginhoux et al., 2010). Microglia genesis is
highly dependent on Csf-1r signaling (Ginhoux et al., 2010). In
order to determine whether microglia precursors require IL-34
signaling during embryogenesis, we analyzed the brain rudiment
of Il34LacZ/LacZ embryos at E10.5, E14.5, and E17.5 (Figures 4C
and 4D). Microglia precursors were present at normal numbers
in the absence of IL-34 throughout embryonic development.
Similar results were obtained in neonatal Il34LacZ/LacZmicewhere
no difference could be detected in microglia numbers compared
to control mice (Figure 4E). These data indicated that IL-34 is
dispensable for the embryonic development of microglia but
contributes to microglia homeostasis in certain regions within
the CNS in the adult.
IL-34 Does Not Control the Inflammation-Induced
Repopulation of LCs but Is Crucial for Their
Maintenance In Vivo
Under physiological conditions, adult LCs self-renew indepen-
dently of blood-derived precursors (Merad et al., 2002). During
skin inflammation, however, the pool of resident LCs is replen-
ished by circulating Ly6Chi monocytes. Repopulation of resident
LCs under inflammatory conditions is highly dependent on Csf-
1r signaling (Ginhoux et al., 2006). To determine whether Csf-1r
signaling is also required for the maintenance of adult mono-
cyte-derived LCs, we generated mixed BM chimeras. RecipientImmmice were lethally irradiated and reconstituted with a 1:1
mixture of CD45.1 WT: CD45.2 Langerin-Cre+ 3 Csf1rfl/fl BM
cells or CD45.1 WT: CD45.2 WT BM cells. Mixed chimeras
were then exposed to UV light and analyzed for the presence
of LCs (CD45.1+ versus CD45.2+) once the inflammation is
resolved, which usually occurs in about 2 weeks post UV expo-
sure in our model (Merad et al., 2002). Langerin-Cre+ 3 Csf1rfl/fl
LCs were greatly reduced compared to WT LCs in the same BM
chimera and compared to CD45.1 WT: CD45.2 WT BM chimeric
animals (Figure S3A). Of note, there was no difference in the
chimerism of blood monocytes before UV treatment in both
groups of chimeras (data not shown). These data indicate that
Csf-1r signaling is critical for the homeostasis and/or survival
of the newly repopulated LCs. We have previously shown that
the repopulation of LCs by Ly6Chi monocytes in the UV-
exposed skin is delayed but not aborted in Csf1op/op mice (Gin-
houx et al., 2006), suggesting that IL-34-mediated Csf-1r
signaling could be involved in the repopulation of LCs in in-
flamed skin. Here, we explored whether monocytes are re-
cruited to the inflamed skin and can give rise to LCs in the
absence of IL-34. To this end, Il34LacZ/+ and Il34LacZ/LacZ mice
were exposed to UV light. We found that at the peak of acute
skin inflammation (day 7 after UV exposure), numbers of skin-
infiltrating monocytes were comparable between Il34LacZ/+ and
Il34LacZ/LacZ mice (Figure 5A). At this time point, resident
epidermal LCs were drastically decreased compared to naive
Il34lacZ/+ mice (Figure 5A). However, 21 days after UV exposure,
the epidermis of Il34LacZ/LacZ mice harbored fewer LCs in
comparison to control mice, whereas at 45 days and 90 days
after UV exposure, LCs were severely reduced in Il34LacZ/LacZ
mice compared to Il34LacZ/+ (Figure 5B). Because Csf-1r is
required for the differentiation of monocytes into LCs in the in-
flamed skin, these results suggest that Csf-1 might compensate
for the lack of IL-34 allowing the recruitment of monocytes and
their subsequent differentiation into LCs in the inflamed
epidermis of IL-34-deficient mice, but that in the steady state,
the only Csf-1r ligand that can maintain LC homeostasis is IL-
34. To confirm this notion, we examined the expression of IL-
34 and Csf-1 in the epidermis of WT mice at different time points
post UV exposure (Figure 5C). Accordingly, we found that
during severe skin inflammation (day 7), IL-34 was decreased
but the levels of Csf-1 were highly increased in the epidermis.
After the inflammation was resolved (day 21 and day 42), IL-
34 levels increased again to levels observed in uninflamed
skin (Figure 5C). Clearly IL-34 is not needed for the influx of
monocyte-derived LCs during inflammation. However, after
resolution of inflammation, monocyte-derived LCs require IL-
34 for their maintenance.
To confirm these findings in a different skin inflammation
model, we administered Calcipotriol locally to the skin. Calcipo-
triol is a Vitamin-D3 analog that induces proliferation of kerati-
nocytes and inflammation when applied to healthy skin (Li
et al., 2006b). We found that similar to UV-induced skin inflam-
mation, Calcipotriol leads to the depletion of resident LCs and,
this cellular niche is subsequently replaced by BM-derived circu-
lating precursors that proliferate locally and differentiate into
LCs (Figures S3B and S3C). Upon Calcipotriol-induced in-
flammation, LCs were repopulated in Il34LacZ/LacZ mice (Figures
5D and 5E). However, similar to what we observed in theunity 37, 1050–1060, December 14, 2012 ª2012 Elsevier Inc. 1055
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Figure 5. IL-34 Is Not Critical for the Repopulation of LCs in Inflammation but for Their Maintenance
(A and B) Il34LacZ/LacZ and Il34LacZ/+ mice were exposed to UV light. (A) Plots show the percentage and total cell number (±SEM) of monocytes (CD11b+Ly6C+)
among ear skin cell suspensions (CD45+ Ly6G) and of LCs (Epcam+Langerin+) amongCD45+ epidermal cells 7 days (d) after UV treatment or in untreated control
mice (n = 4 for UV-treated groups and n = 3 for untreated control mice). Data are pooled from two individual experiments. *p < 0.05, **p < 0.01, ***p < 0.001
(Student’s t test, unpaired). (B) Plots show the percentage and total cell number (±SEM) of LCs (Epcam+Langerin+) amongCD45+ epidermal cells on day 21 (n = 7),
day 45 (n = 7) and day 90 (n = 5) after UV exposure. Pooled data of two individual experiments. *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test, unpaired).
(C) Quantitative RT-PCR analysis of Il34 and Csf1mRNA levels in the epidermis of UV exposed WTmice at different time points post UV exposure or in naive WT
mice (d 0). Data were normalized to the expression of RNA polymerase 2 (n = 3 for d 7, d 21 and d 42, n = 2 for d 0).
(D and E) Il34LacZ/LacZ and Il34LacZ/+mice were treated with Calcipotriol (CP) for 2 weeks and epidermal cells were analyzed 21 days post treatment. (D) Plots show
the percentage of LCs among CD45+ epidermal cells. Graph displays the total cell number (±SEM) of LCs of CP-treatedmice (n = 6). Pooled data of two individual
experiments are shown. (E) Images depict anti-MHCII staining on ear-derived epidermal sheets of Il34LacZ/LacZ and Il34LacZ/+ mice 21 days after CP treatment
(scale bar represents 100 mm).
(F and G) Ears of Il34LacZ/LacZ and Il34LacZ/+mice were treated with Aldara cream for 9 days (n = 4). Shown is one representative of two individual experiments. (F)
Kinetics of Aldara-induced skin inflammation measured by increase in ear thickness. (G) Plots show the percentage and total cell number (±SEM) of LCs among
CD45+ epidermal cells of Aldara treated ears on day 12 (n = 7). *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test, unpaired).
Immunity
IL-34 Controls Langerhans Cells and MicrogliaUV inflammationmodel, 3 weeks after Calcipotriol treatment, the
total number of monocyte-derived LCs in Il34LacZ/LacZ mice was
reduced compared to Il34LacZ/+ mice. No difference in pheno-
typic markers or morphology of LCs could be observed between
Il34LacZ/LacZ and Il34LacZ/+ mice at this time point (Figure 5E).
Thus, the recruitment of monocytes and their subsequent differ-
entiation into LCs under inflammatory conditions is independent1056 Immunity 37, 1050–1060, December 14, 2012 ª2012 Elsevier Inof IL-34, but once the inflammation resolves, the maintenance
of these newly recruited LCs requires IL-34 signaling.
LCs Are Not Involved in Aldara-Induced Psoriasiform
Inflammation
Psoriasis is a common relapsing and remitting inflammatory
skin disease manifested by scaly erythematous plaques withc.
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Figure 6. IL-34 Is Expressed in Human Skin and Brain
(A) Quantitative RT-PCR analysis of Il34 and Csf1mRNA expression of human
epidermis and dermis. Data were normalized to the expression of GAPDH.One
of two independent experiments is shown.
(B) Human skin sections were stained with mAbs against K14 and IL-34 (or
isotype, mouse IgG1) and counterstained with DAPI (scale bar represents
50 mm).
(C) Human brain sections of the temporal lobe were stained with mAbs against
IL-34 (or isotype, mouse IgG1) and NeuN and counterstained with Dapi (scale
bar left represents 20 mm, scale bar right represents 5 mm).
Immunity
IL-34 Controls Langerhans Cells and Microgliasilvery-white scaling and acanthosis. The psoriasiform skin
lesions are characterized by hyperproliferative keratinocytes,
infiltration of macrophages, DCs, neutrophils, and T cells (Perera
et al., 2012). Although the pathogenesis of psoriasis is not clearly
defined, IL-23-induced IL-17 secretion is essential for the psor-
iasiform plaque formation in mice as well as humans (van der
Fits et al., 2009). We and others have recently demonstrated
that skin-invading gd T cells and innate lymphocytes producing
the ‘‘TH17 cell–signature cytokines’’ (IL-17A, IL-17F, and IL-22)
rather than TH17 cells, as sufficient and necessary in Aldara-
induced skin inflammation (Cai et al., 2011; Pantelyushin et al.,
2012). Even though LCs produce IL-23 (Igya´rto´ et al., 2011)
and reside in close proximity to keratinocytes, their contribution
to the pathogenesis of psoriasiform inflammation is not known.
In order to address the role of LCs in the development of
Aldara-induced psoriasiform lesions, we exposed the skin of
Il34LacZ/LacZ mice to Aldara cream as described previously
(Pantelyushin et al., 2012). Ears of Il34LacZ/+ and Il34LacZ/LacZ
mice were treated with Aldara cream for 9 days and the kinetics
of inflammation was assessed by increase in ear thickness. No
difference in the kinetics of Aldara-induced skin inflammation
could be detected between Il34LacZ/+ and Il34LacZ/LacZ miceImm(Figure 5F). Analysis of skin infiltrating cells e.g., gd T cells
or DCs also revealed no difference between Il34LacZ/+ and
Il34LacZ/LacZ mice (data not shown). In addition, similar to Calci-
potriol and UV-induced skin inflammation, in Aldara-induced
skin inflammation, LCs were repopulated in Il34LacZ/LacZ mice
although at significantly lower numbers compared to Il34LacZ/+
mice (Figure 5G). These data indicate that LCs are dispensable
for the formation and the pathogenesis of psoriasiform plaques
but confirm that IL-34 controls LC homeostasis in adult
epidermis.
IL-34 Is Expressed in Human Skin and Brain
To determine whether our findings could also be translated to
humans, we investigated human brain tissue obtained from
intractable epilepsy patients undergoing selective amygdalahip-
pocampectomy and skin tissue obtained from patients under-
going reductive mammoplasty. Il34 messenger RNA (mRNA)
was previously shown to be expressed in several human tissues
including lung, liver, kidney, brain, spleen, thymus, testis, ovary,
and gut (Lin et al., 2008). However, the expression of IL-34
protein and its localization within the skin and the brain has not
been previously reported. We found that IL-34 was the only
Csf-1r ligand expressed in the human epidermis where it was
produced by keratinocytes mirroring our finding in rodents,
whereas both IL-34 and Csf-1 were expressed in the human
dermis (Figures 6A and 6B). In the human brain, IL-34 protein
was also readily detectable in the temporal lobe as shown in
Figure 6C. These results establish that the expression pattern
of IL-34 is comparable between species, indicating that IL-34
is an evolutionary highly conserved, nonredundant factor con-
trolling microglia and LC homeostasis.
DISCUSSION
Csf-1r and its ligand Csf-1 have long been recognized asmanda-
tory factors for the differentiation, maintenance, and function of
tissue macrophages. Interestingly however, mice lacking Csf-
1r display significantly more severe developmental abnormalities
than mice lacking the ligand Csf-1. Specifically, LCs and micro-
glia are absent in Csf1r/ mice, whereas they display only
a slight reduction in numbers in Csf1op/op mice. By specifically
ablating Csf-1r on fully differentiated LCs, we could demonstrate
that Csf-1r signaling is not only required for the development of
LCs during embryogenesis but is also a prerequisite for the
homeostasis of LCs in the adult skin. Consequently, these find-
ings imply that another ligand apart from Csf-1 controls LC
homeostasis in the adult skin.
This phenotypic divergence between Csf1r/ and Csf1op/op
mice could potentially be explained by the recent discovery of
an alternative ligand for Csf-1, named IL-34. Here, we analyzed
the role of IL-34 in the development of LCs and microglia. By
using IL-34-deficient reporter mice, we found that within the
skin, IL-34 was almost exclusively produced by keratinocytes
in the epidermis and by neurons in the brain. During the prepara-
tion of this manuscript, a report by Wang et al. (2012) also
demonstrated that adult Il34LacZ/LacZ mice displayed a drastic
reduction of LCs, indicating that IL-34 is a key regulator for
LCs in agreement with our study. Similar to mice, IL-34 was
also the only Csf-1r ligand expressed in human epidermis.unity 37, 1050–1060, December 14, 2012 ª2012 Elsevier Inc. 1057
Immunity
IL-34 Controls Langerhans Cells and MicrogliaIn both mouse and human skin, we found IL-34 expression
also in the dermis. The expression of dermal IL-34 was localized
mainly to hair follicles in mice suggesting that hair follicle IL-34
expression could play a role in LC entry as demonstrated by
Nagao et al. (2012).
In the brain, the deficiency of IL-34 only led to a decrease in
microglia cell numbers by approximately 50% in a region-
specific manner. This phenomenon suggests that within the
CNS, Csf-1 might compensate for the loss of IL-34. Such
compensatory Csf-1 expression was not observed within the
epidermis, in agreement with the absence of Csf-1 expression
in the epidermis. The fact that DCs and macrophages in other
lymphoid and nonlymphoid tissues were unchanged in the
absence of IL-34, demonstrates the tissue and target specificity
of stroma-derived IL-34 on the MPS.
Wang et al. (2012) also observed developmental defects in
LCs as well as microglia as illustrated by the lack of both cell
populations in Il34Lac//LacZ neonatal mice. We observed the
same phenotype in the neonatal skin; however, we failed to
observe such a reduction of microglia in IL-34-deficient
neonates. We thus extended these studies and analyzed the
development of microglia and LC precursors during embryogen-
esis. In the developing skin at E10.5 and E14.5, LC precursors
were present at normal numbers in the absence of IL-34.
However, in the developing epidermis at E17.5, LC precursors
were significantly reduced in Il34Lac//LacZ embryos compared to
control littermates. This reduction of LC precursors in E17.5
Il34Lac//LacZ embryos correlated with the upregulated IL-34
expression in E17.5 epidermis in WT embryos. No differences
were found in myeloid cell numbers in other organs or in micro-
glia precursors in the developing brain throughout embryogen-
esis. These data indicate that LC precursors in the embryonic
epidermis required IL-34 locally for their survival and/or differen-
tiation into LCs, whereas the development of microglial cells was
not exclusively dependent on IL-34 signaling. As mentioned
above, we hypothesize that the expression of Csf-1 in the CNS
parenchyma compensates for the loss of IL-34.
In three different skin inflammation models, we could show
that the recruitment of monocytes and their subsequent devel-
opment into LCs was not inhibited in the absence of IL-34,
which is in agreement with the study published by Wang et al.
(2012). However, upon longitudinal analysis, we found that
after resolution of inflammation, the total number of LCs was
significantly reduced and declined over time in Il34LacZ/LacZ
mice. During acute skin injury induced by UV light, we found
Il34 to be present at low levels in the epidermis compared to
the steady state. Conversely, Csf1, which is absent from the
epidermis in the steady state, was highly upregulated after UV
exposure. These findings indicate that LC differentiation in an
inflamed setting could occur independently of IL-34 but that
the homeostasis of monocyte-derived LCs in the adult skin
requires IL-34.
Taken together, our data revealed that IL-34 represents
a unique cytokine, in that its expression is highly restricted to
stromal cells of the epidermis and brain in both mice and
humans. The fact that the expression pattern of IL-34 is compa-
rable between these species is also indicative of a highly
conserved evolutionary pathway. The identification of the IL-34
encoding gene and protein in avian species also adds credence1058 Immunity 37, 1050–1060, December 14, 2012 ª2012 Elsevier Into this prospect (Garceau et al., 2010). Thus, IL-34 represents
a cytokine essential for the development and maintenance of
LCs and homeostasis of microglia.
EXPERIMENTAL PROCEDURES
Mice
To generate IL-34-deficient mice, targeted JM8.N4 embryonic stem cells were
obtained from EUCOMM (IKMC Project - ID: 33127). In brief, the L1L2_Bact_P
cassette was placed upstream of exons 3–5. In this constellation (termed
Il34LacZ), usage of the En2 (engrailed 2) splice acceptor will result in a fusion
message between the first two exons and the LacZ reporter sequence, result-
ing in a truncated Il34message.Csf1rfl/fl mice were provided by Jeffrey Pollard
(Li et al., 2006a) (Albert Einstein, New York, NY). Langerin-Cre mice were
provided by Daniel Kaplan (Kaplan et al., 2007) (University of Minnesota, Min-
neapolis, MN). All animal experiments performed in this study were approved
by the Institutional Animal Care and Use Committee (IACUC) of Mount Sinai
School of Medicine and by the Swiss Veterinary Office.
Blocking Csf-1r Signaling
Csf-1r mAb (clone AFS98) was purified from culture supernatant of
AFS98 hybridoma (gift from S. Nishimura, New York) as previously described
(Hashimoto et al., 2011). Mice were injected intraperitoneally (i.p.) with AFS98
or isotype (rat IgG2a, clone 2A3, Bio X Cell) at doses of 2 mg/mouse on day
0 and 1 mg on days 2 and 4 and analyzed on day 12 after treatment start.
Rosa26-CreERT2 3 Csf1rfl/fl were injected i.p. with 2.5 mg tamoxifen (Sigma
T5648) dissolved in corn oil three times every other day as previously
described (Greter et al., 2012).
Cell Suspension Preparations
Cell suspensions were prepared as previously described (Ginhoux et al.,
2009). Epidermis and dermis were separated after Dispase digestion, cut
into small pieces, and incubated for 2.5 hr in 0.2 mg/ml collagenase type
IV (Sigma-Aldrich) and passed through a 19G syringe to obtain a homoge-
neous cell suspension. CNS, spleen, lung, lymph nodes, and liver were incu-
bated in collagenase type IV and subsequently passed through a19G syringe
to obtain a homogeneous cell suspension. Liver and CNS cell suspensions
were further enriched by a Percoll gradient as previously described (Ginhoux
et al., 2009, 2010). Analysis was carried out by flow cytometry as described
below.
Flow Cytometry
Flow cytometry was performed using an LSRII or LSRII Fortessa (Becton
Dickinson) and analyzed with FlowJo software (Tree Star). Fluorochrome-
conjugated monoclonal antibodies (mAbs) specific for mouse MHC class II
I-A/I-E (clone M5/114.15.2), CD11b (clone M1/70), CD11c (clone N418),
CD45 (clone 30-F11), CD115 (clone AFS98), Ly6C (clone AL-21), Ly6G (clone
1A8), CD103 (clone 2E7), CD8a (clone 53-6.7), CD24 (clone M1/69), and
Epcam (cloneG8.8) were purchased either fromBDBiosciences, eBioscience,
or Biolegend. Anti-F4/80 (clone Cl:A3-1) mAb was purchased from AbD Sero-
tec. Anti-Langerin Ab (clone E-17) and donkey-anti-goat IgG-PE were
purchased from Santa Cruz.
Quantitative RT-PCR
Total RNA was extracted from tissues using the RNeasy Mini kit (QIAGEN) and
reverse-transcribed into cDNA using MML-V reverse transcriptase (Invitrogen)
or Superscript II RT (Invitrogen) followed by PCR amplification with Platinum
SYBR Green qPCR SuperMix-UDG (Invitrogen) or SYBR Green I Master Mix
(Roche). The following primers were used: mouse IL-34 forward: ACTCA
GAGTGGCCAACATCACAAG, mouse IL-34 reverse: ATTGAGACTCACCAA
GACCCACAG, mouse Csf-1 forward: TACAAGTGGAAGTGGAGGAGCCAT,
mouse Csf-1 reverse: AGTCCTGTGTGCCCAGCATAGAAT, mouse pol2
forward: CTGGTCCTTCGAATCCGCATC, mouse pol2 reverse: GCTCGATAC
CCTGCAGGGTCA, human Csf-1 forward: GTTTGTAGACCAGGAACAGTT
GAA, human Csf-1 reverse: CGCATGGTGTCCTCCATTAT, human GAPDH
forward: ATGGGGAAGGTGAAGGTCG, human GAPDH reverse: GGGTCAT
TGATGGCAACAATATC. For the embryo analysis (Figure 4), the followingc.
Immunity
IL-34 Controls Langerhans Cells and Microgliaprimers were used: mouse IL-34 forward, GGGTCATGGAACTGCTGTACT,
mouse IL-34 reverse: ATCAAGGACCCCGGACTG, mouse Csf-1 forward:
CTGCTTCACCAAGGACTATGAG, mouse Csf-1 reverse: GAAGTTCTTGATCT
TCTCCAGCA, mouse HPRT1 forward: TCCTCCTCAGACCGCTTTT, and
mouse HPRT1 reverse: CCTGGTTCATCATCGCTAATC.
X-gal Staining and Immunohistochemistry
X-gal Staining
Tissues were fixed in 2% Formaldehyde/0.2% Glutaraldehyde for 1 hr and
then stained in X-gal solution (1 mg/ml X-gal (Sigma), 2 mM MgCl2, 5 mM
K3Fe(CN)6, 5 mM K4Fe(CN)6, 0.02% NP-40, 0.01% sodium deoxycholate)
for 14–16 hr at 37C. Tissues were then fixed in HOPE I (DCS Innovative
Diagnostik-System) for 72 hr and embedded in paraffin. Sections were
stained with antibodies against K14 (Abcam, clone LL002) or NeuN (Millipore,
clone A60) and counterstained with Nuclear fast red solution (Sigma) or
Berlinerblau.
Epidermal Sheets
Epidermal sheets were prepared as previously described (Ginhoux et al., 2006)
and stained with mAb against MHCII (clone M5/114.15.2) and CD3 (clone
145-2C44).
Human Brain and Skin
Snap-frozen temporal lobe tissue specimen was obtained from patients with
chronic pharmacoresistant epilepsy undergoing selective amygdalohippo-
campectomy (University Hospital Zu¨rich, Switzerland) and embedded in
OCT. Human skin obtained from breast reduction (University of Zu¨rich,
Switzerland) was embedded fresh in OCT and snap frozen. Sections (10 mm)
of brain or skin tissue were stained with primary antibodies against IL-34
(Abcam, clone 1D12) or isotype (mouse IgG1, Sigma, clone MOPC21), NeuN
(Millipore, clone A60) or K14 (Abcam, clone LL002) followed by staining with
secondary fluorochrome-conjugated anti-mouse antibodies and counterstain-
ing with DAPI.
All procedures were conducted in accordance with the Declaration of
Helsinki and approved by the Ethics Committee of the Canton Zurich. Informed
written consent was obtained from all patients.
Mouse Brain
Sections (10 mm) of paraffin embedded brains were stained with anti-Iba-1anti-
body (Wako) followed by staining with secondary HRP-conjugated anti-rabbit
antibodies and counterstaining with hematoxylin.
Images were acquired with a Leica SP5 confocal microscope or with
a brightfield microscope (Olympus) and were processed using ImageJ
Software (NIH).
Skin Inflammation
Aldara Treatment
A daily dose of 5 mg of Aldara cream (5% IMQ cream, 3M Pharmaceuticals)
was applied onto the ear for 9 days as previously described (Pantelyushin
et al., 2012).
Calcipotriol Treatment
Calcipotriol (Sigma) (10 nmol) diluted in ETOH was applied every other day
onto the ear for 14 days.
UV Treatment
Mice were exposed to UV light (254 nm, 28 cm from the target) for 25 min as
previously described (Merad et al., 2002).
Statistical Analysis
Mean values, SEM values, and Student’s t test (unpaired) were calculated with
Prism (GraphPad software). *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test,
unpaired).
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